Table 3.
Method | Target | Type of probe | Applications | Advantages | Limitations |
---|---|---|---|---|---|
Molecular beacons (MBs) | DNA/RNA | DNA/RNA | Pathogen detection | Sensitive, high signal to background ratio | It needs a reagent to introduce MBs to living cell |
Stem cell isolation | Endonucleases cleave MBs, limiting live cell application | ||||
Cancer detection | Affected by temperature and pH shift | ||||
Aptamers | Inorganic molecules | DNA/RNA | Diagnostics | Wide range of targets | SELEX protocol is time consuming and laborious |
Toxins Metabolites |
Therapy | High affinity binding to targets | Probes selected in vitro condition do not work well under physiological condition | ||
Nucleic acids | Modifications possible | Relatively unstable in biological fluids | |||
Carbohydrates | Synthesis is cheaper and reproducible | SELEX protocol varies with target | |||
Amino acids | No immunogenicity | ||||
Peptides | Aptamers may not require reagents to introduce to living cells | ||||
Proteins | |||||
Complex biological structures | |||||
Peptide nucleic acid probes (PNPs) | Nucleic acids miRNA | PNA | Diagnostics | High specificity | Cannot cross cell membranes, limiting live cell application |
Therapy | Not detected by nucleases or proteases | ||||
Stable over a wide pH range | |||||
Targeting cell-penetrating peptides (targeting CPPs) | Proteins | Peptides | Translational medicine | Easy to synthesis | Degradation by proteases |
Therapy | Easy to modify | Limited to targets, whose interacting partners and interacting regions are known | |||
High affinity binding to targets | |||||
Less immunogenicity |